Efficacy and safety of low dose ponatinib in a case of Ph‐positive acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of low dose ponatinib in a case of Ph‐positive acute lymphoblastic leukaemia

Published:2019-08 Issue:1 Volume:187 Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Marchesi Francesco¹^ORCID,Salvatorelli Emanuela²,Renzi Daniela¹,Mengarelli Andrea¹,Minotti Giorgio²³,Menna Pierantonio³^ORCID

Affiliation:

1. Haematology and Stem Cell Transplant Unit IRCCS Regina Elena National Cancer Institute Rome Italy

2. Drug Sciences, Department of Medicine and Centre for Integrated Research University Campus Bio‐Medico Rome Italy

3. Clinical Pharmacology Unit University Hospital Campus Bio‐Medico Rome Italy

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16132

Reference9 articles.

1. Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion

2. Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias

3. Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients

4. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

5. Ponatinib: Accelerated Disapproval

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens;Hematology;2024-04-06

2. Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis;Hematology, Transfusion and Cell Therapy;2021-06

3. The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study;Annals of Hematology;2021-03-28

4. Monitoring Ponatinib in a Child with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia;Case Reports in Oncology;2021-02-15

5. The cancer patient and cardiology;European Journal of Heart Failure;2020-10-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3